A clinical investigation conducted in all five Finnish university hospitals and sponsored by Injeq has begun in May. A peer-reviewed article that describes the protocol of this large multicenter study has now been published in Trials (link to the journal).
The study is a multicenter, randomized, two-arm crossover noninferiority trial of pediatric hemato-oncology patients that will be conducted within the usual clinical workflow. The study will provide sound scientific evidence on the clinical benefit, performance, and safety of Injeq IQ-Tip system compared with the standard clinical practice of using conventional spinal needles in the LP procedures of pediatric patients with leukemia.
